SYMPOSIA PAPER Published: 01 January 2007
STP45223S

The Role of TGA-DTA in the Initial Evaluation of the Solid State Forms for Pharmaceutical New Chemical Entities, Part 2: Evaluation of Mixed Forms

Source

TGA-DTA plays a central role in the strategy outlined for early evaluation of the solid state forms available to pharmaceutical new chemical entities. Understanding of the solid state forms becomes more difficult when individual samples present as mixed forms, especially when it is not immediately recognized that the samples represent a mixture. In this study, TGA-DTA, in combination with light microscopy and powder X-ray diffraction, provided immediate evidence that samples represented mixed solid state forms. The initial assessment was made using as little as 5 mg of sample. Hygroscopicity challenges provided further proof for mixed forms. To make a definite assignment of the solid state forms present, isolation of pure phases of the suspected individual forms was necessary. Success of this testing strategy is illustrated using an example of mixed salt stoichiometry and mixed hydration states. A hierarchy is suggested for efficient isolation efforts when a complex mixture of solid state samples is present.

Author Information

Redman-Furey, Nancy, L.
P&G Pharmaceuticals, Inc., Norwich, New York
Dicks, Michael, L.
P&G Pharmaceuticals, Inc., Norwich, New York
Godlweski, Jane
P&G Pharmaceuticals, Inc., Norwich, New York
Vaughn, Dana, C.
P&G Pharmaceuticals, Inc., Norwich, New York
Collins, Wendy, J.
P&G Pharmaceuticals, Inc., Norwich, New York
Price: $25.00
Contact Sales
Related
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center
Details
Developed by Committee: E37
Pages: 33–41
DOI: 10.1520/STP45223S
ISBN-EB: 978-0-8031-6236-5
ISBN-13: 978-0-8031-5616-6